PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.35 +0.01 (+2.94%)
At close: Oct 22, 2026 · 4:00 PM EDT

PharmaCyte Biotech (PMCB) Non-Current Debt (2020 - 2021)

Updated

PharmaCyte Biotech's Non-Current Debt was $75,200 in fiscal Q3 2021 (quarter ended Jan 31, 2021), unchanged from the prior quarter.

Analysis

PharmaCyte Biotech (PMCB) Non-Current Debt (2020 - 2021) Analysis & Trends

At the end of FY2020 (ended Apr 30, 2020), Non-Current Debt at PharmaCyte Biotech came in at $46,282.

  • Per Business Quant data, PMCB's Non-Current Debt in the three fiscal quarters before Q3 2021 was $75,200 (Q2 2021), $75,200 (Q1 2021) and $46,282 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 35.80 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 62.48 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 23.68 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 23.83 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 60.50 Bn
10 PharmaCyte Biotech 3.76 Mn -69.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2021 75,200.00
Oct 31, 2020 75,200.00
Jul 31, 2020 75,200.00
Apr 30, 2020 46,282.00
API Access

PharmaCyte Biotech Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=PMCB&period=max&api_key=YOUR_API_KEY